NT5E and lung cancer: One study showed that CD73-ADC treatment can induce a strong intracellular accumulation of pro-inflammatory macrophages and activated dendritic cells in lung cancer cells, which is effective in inhibiting CD73-dysregulated tumors and improving immune responses (47).